Independent influence of insulin, catecholamines, and thyroid hormones on metabolic syndrome (Q46417013)

22 December 2017

title

Independent influence of insulin, catecholamines, and thyroid hormones on metabolic syndrome (English)

1 reference

22 December 2017

1 reference

Giovanni De Pergola

1 reference

22 December 2017

author name string

Francesco Giorgino

1 reference

22 December 2017

Ritanna Benigno

1 reference

22 December 2017

Pietro Guida

1 reference

22 December 2017

Riccardo Giorgino

1 reference

22 December 2017

publication date

14 August 2008

1 reference

22 December 2017

published in

Obesity

1 reference

22 December 2017

volume

1 reference

22 December 2017

issue

1 reference

22 December 2017

page(s)

2405-2411

1 reference

22 December 2017

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

cites work

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.382

Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.382

Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.382

Critical evaluation of adult treatment panel III criteria in identifying insulin resistance with dyslipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.382

Use of Metabolic Markers To Identify Overweight Individuals Who Are Insulin Resistant

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.382

Relationship to insulin resistance of the adult treatment panel III diagnostic criteria for identification of the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.382

Insulin resistance, the metabolic syndrome, and incident cardiovascular events in the Framingham Offspring Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.382

Chronic stress at work and the metabolic syndrome: prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.382

Adrenocortical, autonomic, and inflammatory causes of the metabolic syndrome: nested case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.382

Sympathetic neural activation in nondiabetic metabolic syndrome and its further augmentation by hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.382

Neuroadrenergic and reflex abnormalities in patients with metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.382

Insulin resistance and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.382

Effect of central and peripheral body fat distribution on sympathetic and baroreflex function in obese normotensives

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.382

Thyroid function is associated with components of the metabolic syndrome in euthyroid subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.382

Free triiodothyronine and thyroid stimulating hormone are directly associated with waist circumference, independently of insulin resistance, metabolic parameters and blood pressure in overweight and obese women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.382

Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.382

Urinary epinephrine and norepinephrine interrelations with obesity, insulin, and the metabolic syndrome in Hong Kong Chinese.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.382

The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.382

Depressive Symptoms and Stressful Life Events Predict Metabolic Syndrome Among Middle-Aged Women: A comparison of World Health Organization, Adult Treatment Panel III, and International Diabetes Foundation definitions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.382

Dissociation of sympathoexcitatory and vasodilator actions of modestly elevated plasma insulin levels.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.382

Prevalence of hyperinsulinaemia in patients with high blood pressure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.382

Sympathetic neural activation in visceral obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.382

31 March 2020

Identifiers

DOI

10.1038/OBY.2008.382

1 reference

22 December 2017

1 reference

22 December 2017